Treatment guided by molecular imaging technology invented and developed by researchers at Winship Cancer Institute of Emory University shows improved disease-free survival rates for men who have undergone surgical removal of their prostate.
Early endpoints have the potential to get effective drugs to patients faster, but granting approval to drugs—even accelerated approval—comes with the risk that ineffective or even harmful drugs will be given to patients.
